Acadia Healthcare appoints former CEO Debra Osteen as CEO; Chris Hunter departs

Acadia Healthcare Company, Inc.

Debra Osteen appointed CEO and Class I director effective January 20, 2026; previously served as CEO from 2018-2022.
Chris Hunter departed as CEO and resigned from Board effective January 20, 2026; separation agreement terms to be disclosed later.
Osteen receives base salary of $1,061,000, target bonus of 125% of salary, and option to purchase 1,125,000 shares with performance-based vesting.
Company reaffirms FY 2025 guidance: revenue $3.28B-$3.30B, Adjusted EBITDA $601M-$611M, adjusted EPS $1.94-$2.04.
Board will conduct a comprehensive search for a long-term successor while evaluating all paths to enhance shareholder value.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.